Book Value per Share: elevaiskincare.com (ELAB)

Elevai Labs Inc. (ELAB) is demonstrating an expansion phase by releasing innovative skin regeneration products. The trend in book value per share confirms this growth, with the metric currently standing at 27.09. The business relies on robotic component purification to ensure serum purity and is creating a closed ecosystem that connects cosmetologists with the brand's exosome products.

Elevai Labs Inc (ELAB): Share Book Value from 02/21/2024 to 10/28/2026

elevaiskincare.com - analytical breakdowns and key metrics (ELAB)

- price and consensus price forecast:

Stock Price Elevai Skincare|ELAB - Analyst Consensus Forecast

- market capitalization data:

Market Capitalization Elevai Labs Inc.|ELAB - Total Company Value

- book capitalization data:

Net Assets per Single Share Elevai Labs|ELAB - Net Asset Value|Market Capitalization to Book Value Ratio elevaiskincare.com|ELAB - Aggregate Asset Value

- debt and liquidity data:

Total Debt to Capital Elevai Labs Inc.|ELAB - Long-Term Debt to Capital|Short-Term Debt to Equity Elevai Labs|ELAB - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Elevai Labs Inc.

Fundamental company valuation:Elevai Skincare - ELAB

Book value per share is calculated as the ratio of equity minus liabilities to the number of shares, reflecting the actual value of net assets per unit of ownership. Growth in this metric confirms the capitalization of intellectual property in biomedicine and the expansion of Elevai Labs Inc. (ELAB) within the regenerative cosmetics segment, as clearly demonstrated by the book value per share history on the GURU.Markets platform.

Competitors of Elevai Labs Inc. (ELAB)

Krystal Corp - Book Value per Share|APGE - Book Value per Share|Arcutis Biotherapeutics (ARQT) - Book Value per Share|VCEL (vcel.com) - Net Assets per Single Share|Net Assets per Single Share Oruka Therapeutics ORKA|Share Book Value Sanara|DBV Technologies S.A. (DBVT) - Book Value per Share|Accounting Value of a Share solesence.com (SLSN)|Book Value per Share DERM (Journey Medical Corporation)|fortebiorx.com - Book Value per Share|Net Assets per Single Share Empro Group (EMPG)|SLGL: Accounting Value of a Share|AXIL (reviveprocare.com) - Net Assets per Single Share|Medicus Pharma Corp (MDCX) - Accounting Value per Share|VRCA (Verrica Pharmaceuticals Inc) - Book Value per Share|Book Value per Share Hoth (HOTH)|Biofrontera Inc. (BFRI) - Accounting Value per Share|Accounting Value of a Share VYNE (vynetherapeutics.com)|Net Assets per Single Share SNOA|Quoin Pharmaceuticals Ltd - Net Assets per Share|Azitra, Inc. - Net Assets per Single Share|DRMA - Book Value per Share|Revance Therapeutics, Inc. - Book Value per Share